Joined Exact Sciences: 2009
Kevin Conroy is the Chairman and CEO of Exact Sciences. He became CEO 11 years ago and he has been part of a team that transformed Exact Sciences into one of the world’s premier cancer diagnostics companies with more than 4,500 employees.
Mr. Conroy has led Exact Sciences through the development, clinical trial, regulatory approval, and commercialization of its noninvasive colorectal cancer screening test, Cologuard®. This culminated with Cologuard becoming the first medical device or diagnostic to receive simultaneous FDA approval and national Medicare coverage. Since 2014, millions of Americans have used Cologuard to screen for colorectal cancer, the second leading cause of cancer death in the United States.
In 2019, Exact Sciences’ acquisition of Genomic Health, Inc., united two of the industry’s strongest brands, Cologuard and Oncotype DX®, and established the company’s position as the global leader in advanced cancer diagnostics. The global company is working to improve screening, early detection, and treatment guidance throughout the cancer continuum.
Before joining Exact Sciences, Mr. Conroy served as CEO and President of Third Wave Technologies, a molecular diagnostics company that developed a breakthrough cervical cancer screening test before being acquired by Hologic in 2008. Mr. Conroy also held leadership positions at GE Healthcare, a global leader in medical imaging and information technology, and practiced intellectual property law in private practice. Mr. Conroy currently serves as a director of Epizyme, Inc. and Adaptive Biotechnology Corporation.
Mr. Conroy is active in the Wisconsin community. He serves as a director of the Greater Madison Chamber of Commerce and on the University of Wisconsin-Madison Chancellor’s Advisory Council. He has also served as chair of The United Way of Dane County’s 2016 annual campaign and as a board member of Overture Center for the Arts.
A native of Flint, Michigan, Mr. Conroy holds a Bachelor of Science degree in electrical engineering from Michigan State University and earned his Juris Doctorate from the University of Michigan Law School.
“What excites me most about working at Exact Sciences? Solving hard problems with exceptional people. It’s incredibly energizing to know that our collective ability and experience are making a real difference in the early detection of cancer, a space in which few companies have been able to carve out a leadership position. I’m just as excited that we’re putting our skills and know-how to work bringing other products to market where we can make a similar difference.
The mission we’ve outlined and the challenges in front of us put Exact Sciences in a unique leadership position to help win the war on cancer through early detection."